Interactive Investor
>>

Cardiff Oncology Inc (NASDAQ:CRDF) Share Price

CRDF

Cardiff Oncology Inc

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Loading...

Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.TrovaGene Inc is clinical-stage, precision medicine oncology therapeutics company. Its focus is to develop oncology therapeutics for improved cancer care and to optimize drug development by leveraging its Precision Cancer Monitoring technology.

NASDAQ:CRDF

US14147L1089

USD

Loading...

Loading Comparison

Latest CRDF News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News